John Brancaccio - Jun 9, 2022 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Former Director
Signature
/s/ John Brancaccio
Stock symbol
CRDF
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/9/2022, 07:48 PM
Previous filing
May 16, 2022
Next filing
Sep 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRDF Stock Options Other $0 +26.8K +27.2% $0.00 125K Jun 9, 2022 Common Stock 26.8K $2.50 Direct F1
transaction CRDF Stock Options Other $0 +22K +21.29% $0.00 125K Jun 9, 2022 Common Stock 22K $7.98 Direct F2
transaction CRDF Stock Options Other $0 +28.9K +29.92% $0.00 125K Jun 9, 2022 Common Stock 28.9K $2.60 Direct F3
transaction CRDF Stock Options Other $0 +44.7K +55.51% $0.00 125K Jun 9, 2022 Common Stock 44.7K $2.48 Direct F3
transaction CRDF Stock Options Other $0 +755 +0.61% $0.00 125K Jun 9, 2022 Common Stock 755 $21.60 Direct F3
transaction CRDF Stock Options Other $0 +530 +0.42% $0.00 125K Jun 9, 2022 Common Stock 530 $51.84 Direct F3
transaction CRDF Stock Options Other $0 +223 +0.18% $0.00 125K Jun 9, 2022 Common Stock 223 $372.96 Direct F3
transaction CRDF Stock Options Other $0 +223 +0.18% $0.00 125K Jun 9, 2022 Common Stock 223 $516.96 Direct F3
transaction CRDF Stock Options Other $0 +195 +0.16% $0.00 125K Jun 9, 2022 Common Stock 195 $316.08 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the Reporting Person's departure from the Board of Directors, the Compensation Committee accelerated the vesting of 26,800 stock options to June 9, 2022 from March 9, 2023. In addition, the Compensation Committee extended the expiration date of the stock options to June 9, 2024.
F2 In connection with the Reporting Person's departure from the Board of Directors, the Compensation Committee accelerated the vesting of 22,000 stock options to June 9, 2022 from June 10, 2022. In addition, the Compensation Committee extended the expiration date of the stock options to June 9, 2024.
F3 Expiration date of the stock options was extended to June 9, 2024.